AMSTERDAM/LONDON, Oct 13 (Reuters) – Infrastructure fund
manager Highstar Capital is looking to divest its 25 percent
stake in London City Airport, two people familiar with the
matter said, a sale that could fetch up to 200 million pounds
New York-based Highstar, which bought its stake in London’s
sole centrally located airport from Global Infrastructure
Partners (GIP) in 2008, is now looking for an exit and has
approached infrastructure and pension funds, the sources said.
LONDON, Oct 13 (Reuters) – Lazard Ltd (LAZ.N: Quote, Profile, Research, Stock Buzz) has hired
Naguib Kheraj for a new top international role, bolstering its
London offering with a banker previously linked with top jobs at
Lloyds Banking Group (LLOY.L: Quote, Profile, Research, Stock Buzz) and UK insurer Prudential (PRU.L: Quote, Profile, Research, Stock Buzz).
Kheraj, 46, had been chief executive officer (CEO) of
JPMorgan Cazenove, the U.S. bank’s joint venture with Britain’s
Cazenove Group. He left after JPMorgan (JPM.N: Quote, Profile, Research, Stock Buzz) took full control
of the unit earlier this year.
LONDON/ISTANBUL, Oct 12 (Reuters) – An arm of Citigroup
(C.N: Quote, Profile, Research, Stock Buzz) and two other investors are mulling a sale of copycat
drugmaker Biofarma, people familiar with the matter said, in
what could be Turkey’s biggest healthcare deal.
The generic drugmaker, whose full name is Biofarma
Pharmaceutical Industry Co Inc, has met investment bankers and
is close to picking advisers to help prepare the company for a
$500 million-plus sale, these people added. One said it could be
worth nearly $1 billion.
LONDON, Oct 11 (Reuters) – The editors of the Financial
Times, Guardian, Reuters and the Times urged Britain’s markets
watchdog to scrap “misguided” anti-leak rules that will curb
journalists’ contacts with bankers and executives.
Last month, the Financial Services Authority (FSA) told the
firms it regulates, such as banks, brokers and asset managers,
to adopt media policies to kill “strategic leaks.”
MUMBAI/LONDON (Reuters) – Reported fresh attempts to outdo BHP Billiton’s $39 billion bid for Canadian group Potash Corp look unwieldy, analysts said, suggesting the world’s biggest miner still has the field to itself.
Bernstein analyst Paul Galloway said getting the financial clout needed to improve on the terms of the biggest takeover bid this year required either aligning a diverse consortium or relying on the politically contentious backing of China.
LONDON, Oct 7 (Reuters) – The investment arm of the group
that operates Dubai’s tax-free business hub is seeking to sell
financial software company SmartStream Technologies, three
people familiar with the matter said on Thursday.
DIFC Investments, an arm of Dubai’s International Financial
Centre (DIFC), has hired UBS to help sell SmartStream, the
LONDON, Oct 7 (Reuters) – Investcorp INVB.BH, the
Bahrain-based investment bank, plans to float Moneybookers, the
fast-growing European online payment firm it tried to sell last
year, four people familiar with the matter said on Thursday.
Investcorp has hired Morgan Stanley and Jefferies to help
prepare for a stockmarket listing, the people said. Bank of
America Merrill Lynch is also likely to have a role, two of the
LONDON, Oct 6 (Reuters) – AAC Capital, the former private
equity arm of Dutch bank ABN AMRO, is looking to sell IMCD, the
Rotterdam-based chemical distributor with nearly 1 billion
euros in revenue, two people familiar with the matter said on
The Dutch investor has hired UBS as an adviser, and the
process is at an early stage, the people added.
LONDON, Oct 4 (Reuters) – Acision, the mobile-data company
whose technology delivers almost a trillion text messages a
year, has raised $100 million of new funding from its owners,
led by Russian-born billionaire Len Blavatnik.
The company, whose systems are used by eight of the 10
biggest mobile operators, said the fresh capital will help it
invest for growth as devices like Apple Inc’s (AAPL.O: Quote, Profile, Research, Stock Buzz) iPad
drive a huge increase in mobile-data traffic.
LONDON, Oct 4 (Reuters) – Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research, Stock Buzz) will
pay initial interest rates of less than 1 percent on the $15
billion of loans backing its hostile bid for U.S. rare-disease
specialist Genzyme Corp (GENZ.O: Quote, Profile, Research, Stock Buzz), a regulatory filing showed.
On Monday the French drugmaker went hostile with its $18.5
billion bid for Genzyme, taking the offer directly to
shareholders after being rebuffed by Genzyme management.